Positive response to omalizumab in patients with acquired idiopathic nonhistaminergic angioedema

Ann Allergy Asthma Immunol. 2015 May;114(5):418-9.e1. doi: 10.1016/j.anai.2015.02.007. Epub 2015 Mar 4.

Authors

Julián Azofra¹, Carmen Díaz², Ignacio Antépara³, Ignacio Jaúregui³, Ana Soriano³, Marta Ferrer⁴

Affiliations

¹ Sección de Alergia, Hospital Universitario Central de Asturias, Oviedo, Spain. Electronic address: [email protected].
² Sección de Alergia, Hospital Universitario Central de Asturias, Oviedo, Spain.
³ Servicio de Alergia, Hospital de Basurto, Bilbao, Spain.
⁴ Departamento de Alergia, Clínica Universitaria de Navarra, Pamplona, Spain.

PMID: 25747788
DOI: 10.1016/j.anai.2015.02.007

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Angioedema / drug therapy*
Anti-Allergic Agents / therapeutic use*
Antibodies, Anti-Idiotypic / therapeutic use*
Antibodies, Monoclonal, Humanized / therapeutic use*
Female
Humans
Male
Middle Aged
Omalizumab

Substances

Anti-Allergic Agents
Antibodies, Anti-Idiotypic
Antibodies, Monoclonal, Humanized
Omalizumab